Prostate Cancer
ARPIs used in combination with ADT in prostate cancer significantly increased the risk for cardiovascular events.
Adding short-term ADT to high-dose radiotherapy improved disease-free survival for patients with prostate cancer.
PSMA PET/CT imaging before salvage RT improved survival for patients with BCR prostate cancer after radical prostatectomy.
Research shows that acute cystitis often precedes urogenital cancer for adults aged 50 years and older.
A new, dual-mode PET tracer could provide targeted fluorescence and radio guidance during prostate cancer surgery.
Cheryl Matter, PhD, discusses an AI decision support tool that can improve prostate cancer treatment.
A half-dose of abiraterone acetate is potentially as safe and effective as the standard dose for mHSPC and mCRPC.
Researchers mapped how prostate cancer transforms into its deadliest form, NEPC, revealing a new drug target.
The IsoPSA biomarker displays superior diagnostic accuracy in the early detection of prostate cancer, thereby helping to ...
180 Mount Airy Road Suite 205
Basking Ridge, NJ 07920
Connect
The content of this site is intended for healthcare professionals.
© 2025 Physician’s Weekly, a Formedics PropertyAny views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Physician’s Weekly, their employees, and affiliates.